1. Home
  2. VRA vs ACET Comparison

VRA vs ACET Comparison

Compare VRA & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$2.40

Market Cap

60.6M

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$0.48

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
ACET
Founded
1982
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.6M
71.3M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
VRA
ACET
Price
$2.40
$0.48
Analyst Decision
Buy
Buy
Analyst Count
3
4
Target Price
$4.00
$8.50
AVG Volume (30 Days)
1.9M
2.6M
Earning Date
12-11-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$324,296,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$0.45
52 Week High
$4.09
$1.11

Technical Indicators

Market Signals
Indicator
VRA
ACET
Relative Strength Index (RSI) 54.86 32.79
Support Level $1.39 $0.46
Resistance Level $2.06 $0.59
Average True Range (ATR) 0.21 0.04
MACD -0.01 -0.00
Stochastic Oscillator 80.23 8.34

Price Performance

Historical Comparison
VRA
ACET

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: